| advertisement |
|
|
|
|
|
|
CONTACTS: Media
Deanne McLaughlin
Medtronic MiniMed
(818) 576-4325
Investors
Rachael Scherer
Medtronic, Inc.
(763) 505-2694
F O R I M M E D I A T E R E L E A S E
Medtronic Minimed Introduces New Insulin Pump Software Designed To Improve Diabetes Management
Solutions* Software 5.0 Enables Diabetes Patients and Clinicians to View Important Data, Identify Trends and Optimize Diabetes Care
NORTHRIDGE, Calif. - Aug. 6, 2003 -Medtronic MiniMed, the diabetes management business of Medtronic, Inc. (NYSE: MDT), today announced the availability of a new software program, which captures important information from insulin pumps and glucose meters, allowing patients and clinicians to view important data and adjust therapy to improve diabetes care. Solutions* Software 5.0 was introduced at the American Association of Diabetes Educators (AADE) meeting in Salt Lake City.
Solutions Software 5.0 creates easy-to-understand graphs and charts using information from many Medtronic MiniMed insulin pumps and a variety of popular blood glucose meters, including the Paradigm Link(tm) Blood Glucose Monitor. By viewing blood sugar and insulin delivery (basal and bolus) data from the software, clinicians and patients can more easily identify trends and adjust diabetes therapy to improve blood sugar control. Maintaining blood sugar control within a normal range can improve health and extend life for many diabetes patients.
"By having easy-to-read reports during office visits, I am able to quickly assess therapy changes and spend more quality time with my patients to improve their care," said H. Peter Chase, MD, professor of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Services Center, in Denver. "Information contained in these reports is accurate and reliable since the information comes directly from the pump and meter, enhancing my ability to make more informed treatment decisions. Additionally, patients who previously relied on handwritten logbooks can use this software to be more proactive in their own diabetes care."
The software also captures food carbohydrate values entered by the user into Medtronic MiniMed's recently released Paradigm® 512 pump. The new pump uses carbohydrate data in its Bolus Wizard(tm) calculator, which performs complex "diabetes math" and recommends an insulin dosage based upon information preset by the user. The Paradigm 512 pump system's Paradigm Link monitor, co-developed with BD (Becton, Dickinson and Company) (NYSE: BDX), serves as the information conduit, transferring important data from Paradigm insulin pumps to the software stored in a personal computer.
"Solutions Software 5.0 represents an important step forward in data management for clinicians and patients," said Jeffery A. McCaulley, vice president and general manager of Medtronic MiniMed. "When used with our new integrated, 'intelligent' insulin pump and glucose monitor system, users can optimize diabetes therapy by easily sorting data to monitor historical pump, meter and carbohydrate activity. Accurate reports of this kind can help improve diabetes management, making life better for many patients."
Solutions Software 5.0 downloads data from Medtronic MiniMed Models 507C and 508 pumps, Paradigm 511 and 512 pumps, and a variety of blood glucose meters. In addition, Web-enabled users have access to "Solutions on the Web," an Internet-based software "tutorial" to help users navigate through reports to enhance their understanding of this important data.
It is estimated that more than 1 million Americans with Type 1 diabetes and another 3 million Type 2 diabetes patients use insulin to control blood sugar levels, improve their health and attain a better quality of life. High and low blood sugar fluctuations can cause loss of consciousness or even death, as well as long-term complications such as blindness, kidney failure, amputation, impotence and heart disease. For many patients, managing diabetes is difficult without frequent blood glucose monitoring and the use of an insulin pump.
Medtronic MiniMed (www.minimed.com) designs, develops, manufactures and markets advanced infusion systems with a primary emphasis on the intensive management of diabetes. The company's products include external pumps, related disposables, and a continuous glucose monitoring system. Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the world's leading medical technology company, providing lifelong solutions for people with chronic disease. More information about Solutions Software is available online at www.minimed.com.
- 0 -
EDITOR'S NOTE: Detailed information about diabetes, insulin pump therapy and the Paradigm 512 pump and Paradigm Link system is available by accessing Medtronic's online newsroom.
Any statements made about the company's anticipated regulatory approvals are forward-looking statements subject to risks and uncertainties such as those described in the company's Annual Report on Form 10-K for the year ended April 25, 2003. Actual results may differ materially from anticipated results.
|
|||
 |
 |
||
Last Updated: martes octubre 28, 2003 15:57:24
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.